echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > J Neurol Neurosurg Psychiatry: Cerebrovascular disease is a contributing factor for cerebral hemorrhage in patients on anticoagulation therapy

    J Neurol Neurosurg Psychiatry: Cerebrovascular disease is a contributing factor for cerebral hemorrhage in patients on anticoagulation therapy

    • Last Update: 2021-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cerebral small vessel disease (SVD) is the most common cause of non-traumatic spontaneous intracerebral hemorrhage (ICH).
    In a study in Western Europe, patients aged 70 years or younger accounted for 77%, and a study in Western Europe and the United States In the study, patients aged 18 years or older accounted for 77%-85%
    .


    A meta-analysis of randomized controlled trials showed that oral anticoagulants vitamin K antagonists and direct oral anticoagulants (apixaban, dabigatran, edoxaban, and rivaroxaban) are risk factors for cerebral hemorrhage


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.